Cardiff Oncology (CRDF) Interest Coverage Ratio (2011 - 2026)
Cardiff Oncology (CRDF) posted Interest Coverage Ratio of 0.14 for Q4 2025, up 99.13% sequentially from 15.76 in Q3 2025, and up 87.31% YoY from 0.07 in Q4 2024.
Cardiff Oncology (CRDF) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
Cardiff Oncology has reported Interest Coverage Ratio for 15 years, with the latest figure at 0.14 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 87.31% year-over-year to 0.14 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.86 (up 79.49% YoY) and the FY2025 annual result came in at 0.86, up 14.88% from the prior year.
- Interest Coverage Ratio grew to 0.14 in Q4 2025 per CRDF's latest filing, from 15.76 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.14 in Q4 2025 and troughed at 51.89 in Q4 2022.
- A 5-year average of 10.82 and a median of 3.08 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio sank 1119.09% in 2022, then surged 99.49% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 42.72 in 2021, then retreated by 21.47% to 51.89 in 2022, then soared by 99.49% to 0.26 in 2023, then tumbled by 308.46% to 1.08 in 2024, then soared by 87.31% to 0.14 in 2025.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.14, 15.76, and 3.1 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -150.23 |
| Dec 31, 2025 | -0.14 |
| Sep 30, 2025 | -15.76 |
| Jun 30, 2025 | -3.10 |
| Mar 31, 2025 | -3.06 |
| Dec 31, 2024 | -1.08 |
| Sep 30, 2024 | -4.96 |
| Jun 30, 2024 | -10.72 |
| Mar 31, 2024 | -0.61 |
| Dec 31, 2023 | -0.26 |
| Sep 30, 2023 | -26.01 |
| Jun 30, 2023 | -4.41 |
| Mar 31, 2023 | -32.14 |
| Dec 31, 2022 | -51.89 |
| Sep 30, 2022 | -11.34 |
| Jun 30, 2022 | -2.98 |
| Mar 31, 2022 | -3.01 |
| Dec 31, 2021 | -42.72 |
| Sep 30, 2021 | -0.93 |
| Jun 30, 2021 | -0.93 |